What is Ipamorelin?
The short answer
Ipamorelin is a short chain of five amino acids that is made in a lab.
What it is
Ghrelin-receptor agonist that releases GH.
What people look into
Muscle and exercise, aging, sleep
- 10 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Ipamorelin
What it is
- Type
- GH secretagogue pentapeptide
- Also known as
- ipamorelin acetate, ipa
- How it works
- Ghrelin-receptor agonist that releases GH.
Regulatory status
Not FDA-approved How we label status
As of October 4, 2026, Ipamorelin is not FDA-approved for any use and is not on FDA's 503A bulks list.
- Federal (FDA)
- Not FDA-approved
- 503A compounding
- No category (nomination withdrawn; removed from Cat 2 2024-09-27); not on 216.23 as of 2026-10-07; not an approved-drug component; 503B Category 2 (as of October 7, 2026)
- PCAC history
- 2024-10-29: against 0-12-1 (free base and acetate; uses reviewed: GHD, postoperative ileus); FDA staff: against
- WADA 2026
- S2.2.4
Timeline
Scroll sideways to see all columns.
Timeline table
| Date | What happened | Source |
|---|---|---|
| Federal Register notice of an FDA Pharmacy Compounding Advisory Committee meeting lists ipamorelin among bulk drug substances under consideration for the 503A bulks list. | Federal Register, event of September 18, 2024, on federalregister.gov |
US enforcement actions
3 US enforcement actions since 2022.
Actions by US federal and state agencies whose documents name Ipamorelin. Each row links to the government's own document.
Scroll sideways to see all columns.
US enforcement actions table
| Date | Agency | Action | Document |
|---|---|---|---|
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, on fda.gov | |
| US Justice Department | Indictment | Justice Department document, indictment, April 1, 2026, on justice.gov | |
| FDA | Warning letter | FDA document, warning letter, January 26, 2022, on fda.gov |
References
Sources as of October 4, 2026
- FDA: www.fda.gov/media/94155/download
- FDA: www.fda.gov/media/185412/download
- FDA: www.fda.gov/media/182088/download
- FDA: www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- FDA: www.fda.gov/media/94164/download
- FDA warning letter, August 24, 2026
- WADA: www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
- Internet Archive: web.archive.org/web/20241107074712id_/https://www.fda.gov/media/94155/download
- eCFR: www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23
- FDA: api.fda.gov/drug/drugsfda.json